ACTON, Mass.--(BUSINESS WIRE)--Neuroptix Corporation, a Massachusetts-based pioneer in the early detection of Alzheimer’s Disease, today announced that longtime life sciences executives Michael W. Henry and Stephen J. DiPalma have joined the company’s Board of Directors.
